Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Elsevier Business Intelligence

23:25 EST 14th December 2017 | BioPortfolio

Here are the most relevant search results for "Elsevier Business Intelligence" found in our extensive news archives from over 250 global news sources.

More Information about Elsevier Business Intelligence on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Elsevier Business Intelligence for you to read. Along with our medical data and news we also list Elsevier Business Intelligence Clinical Trials, which are updated daily. BioPortfolio also has a large database of Elsevier Business Intelligence Companies for you to search.

Showing News Articles 1–25 of 2,400+ from Elsevier Business Intelligence

Wednesday 13th December 2017

Rare disease focused Acer Therapeutics nets $10.4mm in FOPO

Acer Therapeutics Inc. (rare and orphan diseases) netted $10.4mm in a follow-on public offering of 916.7k common shares at $1...

Virtual Incision closes $18mm Series B round

Virtual Incision Corp. raised $18mm in its Series B financing co-led by first-time backer Sinopharm Capital and returning sha...

Rockwell licenses Triferic to Quimica Europea for Peru

Rockwell Medical Inc. licensed Quimica Europea exclusive rights to sell the anemia therapy Triferic (ferric pyrophosphate) in...

Hookipa brings in €50mm via Series C

Hookipa Biotech AG (immune activation therapies for cancer and infectious diseases) raised €50mm ($59.5mm) in an oversubscr...

Aelin launches, closes €27mm Series A

Aelin Therapeutics has spun off from VIB and raised €27mm ($31.8mm) in its Series A financing from Life Sciences Partners, ...

Public offering nets $570mm for bluebird bio

Gene editing firm bluebird bio Inc. (oncology and severe genetic diseases) netted $570mm through the public sale of 3.24mm co...

Drug Pricing: US House, Senate, Taking Bicameral Go-Slow Approach

Energy & Commerce Health Subcommittee hearing on drug pricing and the supply chain begins information gathering process, ...

Orphans Dominate Products Seeking End-Of-Year Joy From CHMP

Five of the nine products that could this week be recommended for EU approval have orphan designation. The final meeting...&#...

The Impact Of Brexit – Delays, Safety Impacts And Costs Across Four Scenarios

A report from the Office of Health Economics in the UK has quantified the potential levels of drug shortages and... ...

Tuesday 12th December 2017

TC BioPharm and bluebird bio team up for gamma delta CART therapies

TC BioPharm Ltd. and bluebird bio Inc. penned a deal for the discovery and development of CAR-engineered gamma T-cell therapi...

Shandong Yaohua gains Chinese rights to GTI's LuViva cervical scan system

Chinese device distributor Shandong Yaohua Medical Instrument Corp. (SMI) licensed exclusive distribution, sales, and manufac...

NorthSea Therapeutics raises €25mm in Series A round to fund NASH drug development

NorthSea Therapeutics BV (Dutch start-up developing therapies for inflammatory, metabolic, and fibrotic diseases) raised €2...

Shenghuo licenses Asian rights to GTI's LuViva; Shandong later takes over some territories

Guided Therapeutics Inc. granted its current Asian distributor Shenghuo Medical LLC an exclusive license to manufacture, sell...

Cancer Genetics nets $6.5mm through registered direct offering

Cancer Genetics Inc. (molecular diagnostics for cancer) netted $6.5mm through a registered direct offering of 3.5mm units at ...

Neon and Merck study neoantigen immunotherapy combo

Neon Therapeutics and Merck & Co. Inc. entered a trial collaboration to study the combination of Neon’s neoantigen cancer v...

ITEM Medical gains Turkish rights to GTI's LuViva cervical scan, related disposables

Turkish distributor ITEM Medical Technologies Group signed a preliminary license agreement to manufacture and sell in Turkey ...

EU Guideline On Investigational ATMPs Delayed Until Q3 2019

Several factors have contributed towards a delay in the European Medicines Agency's much awaited guideline on investigati...

UK’s NICE Aims To Knock Firms’ Health Economic Models Into Shape

The scientific advice department at UK HTA body NICE is offering a new peer-review service to companies that want to... ...

Monday 11th December 2017

Fennec Pharmaceuticals closes $20mm public offering

Fennec Pharmaceuticals Inc. netted $20mm through a public sale of 2.49mm common shares (including partial exercise of the ove...

GW Pharmaceuticals nets $299.1mm in FOPO

GW Pharmaceuticals PLC (cannabinoid products) netted $299.1mm in a follow-on public offering of 2.76mm American Depository Sh...

Rezolute gets global rights to Xoma's XOMA358 in potential $240mm deal

Concurrent with changing its name from AntriaBio, Rezolute Inc. received exclusive worldwide rights to develop, manufacture, ...

Titan Medical completes up-sized $Cdn21.4mm PIPE

Titan Medical Inc. (robotic MIS system) netted $Cdn21.4mm ($16.7mm) through the private placement of 46mm units at $Cdn0.50 a...

GW Pharmaceuticals nets $260.1mm in FOPO

GW Pharmaceuticals PLC (cannabinoid products) netted $260.1mm in a follow-on public offering of 2.4mm American Depository Sha...

Almirall licenses US, European rights to Athenex's KX2391 for AK

Almirall SA licensed exclusive US and European development and commercialization rights to Athenex Inc.'s Phase III KX2391 fo...

Fennec Pharmaceuticals closes $19mm public offering

Fennec Pharmaceuticals Inc. netted $19mm through a public sale of 2.35mm common shares at $8.50. Funds will support regulator...


Quick Search
Advertisement
 

News Quicklinks